Kinfo
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Shares logo

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Shares

OACCNASDAQFinancial Services·US · USD
$10.75
-0.01 (-0.09%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap264.26M USD
Enterprise value263.34M USD
Trailing P/E38.39
Forward P/E0.00
PEG ratio-3.07
Price / sales0.00
Price / book1.34
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets3.59%
Return on equity3.74%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income6.75M USD
Diluted EPS$0.28
Rev. growth (YoY)0.00%
Balance sheet
Total cash1.18M USD
Total debt11.82K USD
Debt / equity0.00
Current ratio0.73
Book value / share-$0.31
Cash flow (TTM)
Operating cash flow-455.69K USD
Levered free cash flow7.29M USD
Shares & price
Shares outstanding24.58M
Float18.46M
Held by institutions97.24%
Beta0.00
50-day MA$10.76
200-day MA$10.68
52-week high$10.88
52-week low$10.50
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-233.323.52+6.02%2026-03-27-3.78-0.97+74.34%2025-11-282.942.57−12.59%2025-09-10-0.16-0.31−93.75%
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Shares

Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company focused on identifying and completing a business combination in the life sciences sector. Oaktree Acquisition Corp. III Life Sciences currently serves as a blank check vehicle, with no significant commercial operations, and is structured to pursue merger, share exchange, asset acquisition, stock purchase, reorganization, or similar transactions. Its stated investment focus includes businesses in biopharmaceuticals, medical devices, diagnostics, and specialized healthcare services, with an emphasis on opportunities in North America and Europe. The company’s role in the market is to provide a public capital structure that can be used to bring a private operating company into the public markets through a transaction approved by shareholders. Oaktree Acquisition Corp. III Life Sciences is based in Los Angeles, California.

Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Zaid Pardesi
Headquarters
Los Angeles, CA, United States

Frequently asked questions about Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Shares